| Tyzeka (telbivudine) / Novartis |
NCT00057265: A Randomized, Double Blind Trial of LdT (Telbivudine) Versus Lamivudine in Adults With Compensated Chronic Hepatitis B |
|
|
| Completed | 3 | | US, Europe, RoW | telbivudine or lamivudine | Novartis, Novartis Pharmaceuticals | Chronic Hepatitis B | 04/06 | | | |
NCT00115245: Telbivudine Versus Adefovir Dipivoxil in Adults With HBegAg-Positive, Compensated Chronic Hepatitis B |
|
|
| Completed | 3 | | US, Canada, Europe, RoW | Telbivudine (LdT), Adefovir Dipivoxil | Novartis, Novartis Pharmaceuticals | Chronic Hepatitis B | 08/06 | 08/06 | | |
| Completed | 3 | 240 | US, Canada, Europe, RoW | Lamivudine, Telbivudine | Novartis, Novartis Pharmaceuticals | Chronic Hepatitis B | 12/06 | 12/06 | | |
NCT00131742: Telbivudine Versus Lamivudine in Chinese Adults With Compensated Chronic Hepatitis B |
|
|
| Completed | 3 | | RoW | telbivudine, lamivudine | Novartis, Novartis Pharmaceuticals | Chronic Hepatitis B | 01/07 | 01/07 | | |
NCT00275652: A Comparison of the Drug Telbivudine (LdT) and Lamivudine in Adults With Decompensated Chronic Hepatitis B and Evidence of Cirrhosis. |
|
|
| Completed | 3 | 6 | US | LdT (Telbivudine) and lamivudine | Mayo Clinic, Merck Sharp & Dohme LLC | Hepatitis B, Cirrhosis | 08/07 | 08/07 | | |
NCT00412529: Viral Kinetics Study of Telbivudine and Entecavir in Adults With Chronic Hepatitis B |
|
|
| Completed | 3 | 44 | RoW | Entecavir, Telbivudine | Novartis Pharmaceuticals | Hepatitis B, Chronic Hepatitis B | 02/08 | | | |
NCT00376259: Study of Combination Therapy With LdT Plus Adefovir Versus Adefovir Alone |
|
|
| Terminated | 3 | 43 | US, RoW | telbivudine, adefovir dipivoxil | Novartis | Hepatitis B | 08/08 | | | |
NCT00412750: Efficacy and Safety of Telbivudine in Treatment naïve Patients With Hepatitis B e Antigen (HBeAg)-Positive Chronic Hepatitis B (CHB) |
|
|
| Terminated | 3 | 159 | US | Telbivudine (LdT), Sebivo, peginterferon alpha-2a, Pegasys | Novartis | Hepatitis B | 02/09 | 02/09 | | |
NCT00076336: Telbivudine Versus Lamivudine in Adults With Decompensated Chronic Hepatitis B and Evidence of Cirrhosis |
|
|
| Completed | 3 | 232 | US, Canada, Europe, RoW | Telbivudine, LDT600, Lamivudine, Placebo | Novartis Pharmaceuticals | Hepatitis, Hepatitis B, Chronic, Cirrhosis | 12/09 | | | |
| Completed | 3 | 30 | Europe | Telbivudine, Sebivo, Tyzeka, Hepsera, oral adefovir, adefovir | Novartis Pharmaceuticals | Hepatitis B, Chronic | 12/09 | 12/09 | | |
NCT00805675: Effects of Telbivudine and Tenofovir Disoproxil Fumarate Treatment on the Hepatitis B Virus DNA Kinetics in CHB |
|
|
| Completed | 3 | 83 | RoW | Telbivudine, Tenofovir, Telbivudine plus tenofovir | Novartis Pharmaceuticals | Hepatitis B Virus | 12/10 | | | |
TERESA, NCT01595685: Telbivudine Versus Entecavir in Reducing Serum HBsAg Levels in Patients With HBeAg-positive Chronic Hepatitis B |
|
|
| Completed | 3 | 98 | RoW | Telbivudine, Sebivo, Entecavir, Baraclude | Asan Medical Center | Chronic Viral Hepatitis B Without Delta-agent | 12/14 | 12/14 | | |
NCT01204827: Follow Up of Patients Chronic Hepatitis B (CHB) Treated With Sebivo Using the 13C Methacetin Breath Test |
|
|
| Withdrawn | 2/3 | 0 | RoW | 13C Methacetin Breath Test (BreathID) | Hadassah Medical Organization | Chronic Hepatitis B | | | | |
